Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study

Schizophr Res. 2014 Mar;153(1-3):42-7. doi: 10.1016/j.schres.2014.01.019. Epub 2014 Feb 6.

Abstract

Background: Prediction studies in subjects at Clinical High Risk (CHR) for psychosis are hampered by a high proportion of uncertain outcomes. We therefore investigated whether quantitative EEG (QEEG) parameters can contribute to an improved identification of CHR subjects with a later conversion to psychosis.

Methods: This investigation was a project within the European Prediction of Psychosis Study (EPOS), a prospective multicenter, naturalistic field study with an 18-month follow-up period. QEEG spectral power and alpha peak frequencies (APF) were determined in 113 CHR subjects. The primary outcome measure was conversion to psychosis.

Results: Cox regression yielded a model including frontal theta (HR=1.82; [95% CI 1.00-3.32]) and delta (HR=2.60; [95% CI 1.30-5.20]) power, and occipital-parietal APF (HR=.52; [95% CI .35-.80]) as predictors of conversion to psychosis. The resulting equation enabled the development of a prognostic index with three risk classes (hazard rate 0.057 to 0.81).

Conclusions: Power in theta and delta ranges and APF contribute to the short-term prediction of psychosis and enable a further stratification of risk in CHR samples. Combined with (other) clinical ratings, EEG parameters may therefore be a useful tool for individualized risk estimation and, consequently, targeted prevention.

Keywords: Clinical High Risk; Psychosis prediction; QEEG.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Antipsychotic Agents / therapeutic use
  • Brain Waves / drug effects
  • Brain Waves / physiology*
  • Electroencephalography
  • Female
  • Fourier Analysis
  • Humans
  • Male
  • Neuropsychological Tests
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Psychotic Disorders / diagnosis*
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / physiopathology*
  • Retrospective Studies
  • Risk
  • Risk Factors
  • Survival Analysis
  • Young Adult

Substances

  • Antipsychotic Agents